MicroTransponder的封面图片
MicroTransponder

MicroTransponder

医疗设备制造业

Austin,TX 7,491 位关注者

关于我们

MicroTransponder has developed the Paired Vagus Nerve Stimulation System (Paired VNS? System) based on decades of neuroscience research. The Paired VNS? System is designed to treat several neurological conditions. Our initial focus is upper limb deficits among chronic stroke patients.

网站
https://www.Vivistim.com
所属行业
医疗设备制造业
规模
51-200 人
总部
Austin,TX
类型
私人持股
创立
2007

地点

MicroTransponder员工

动态

  • 查看MicroTransponder的组织主页

    7,491 位关注者

    We walk with healthcare providers and stroke survivors throughout the entire Vivistim Paired VNS Therapy process. Here's a guide you can share with your patients and their caregivers so they can know what to expect. 1?? Complete our Getting Started Survey to see if Vivistim might be right for them. 2?? If the stroke survivor meets the survey criteria, they will be contacted by one of our representatives who will guide them through the evaluation process. 3?? To determine if the stroke survivor is eligible for Vivistim Therapy, a rehabilitation professional will evaluate their current hand and arm function. They will then be referred for a consultation with a surgeon to determine if they are a good candidate for the implantation procedure. 4?? Our Market Access Team will support patients and their provider’s office in navigating the insurance process. Vivistim is covered by Medicare, Medicaid, and private insurance with prior authorization on a case-by-case basis. 5?? Simple, outpatient procedure when a surgeon makes a small incision in the neck, to place the lead, and another small incision in the chest, to place the Vivistim implant. Within a few weeks, the doctor will likely clear the stroke survivor for rehab therapy. 6?? Participate in consistent Vivistim Therapy. In-clinic therapy typically lasts 6 weeks, a few times per week. The sessions are focused on active movement tasks while your therapist signals the Vivistim implant to deliver a gentle pulse to the vagus nerve. You can activate Vivistim with a simple Magnet swipe at home, during therapy exercises or daily activities, as you work to continue improving what matters to you most. To take our Getting Started Survey and review Vivistim safety information, visit https://qrcodes.pro/vbdPY7.

    • We walk with healthcare providers and stroke survivors throughout the entire Vivistim Paired VNS Therapy process. Here's a guide you can share with your patients and their caregivers so they can know what to expect.
  • ?? Los Angeles -- OTs / PTs - Bring your passion for neuro-focused therapy to one of the fastest-growing stroke companies! MicroTransponder is #nowhiring Therapy Development Specialists in key markets. ?? ?? Prior experience as occupational or physical therapist ?? Identify stroke survivors for Vivistim Therapy ?? “Vivistim Paired VNS Patient Expert” ?? Passionate patient advocate ?? Manages and expands stroke rehabilitation facilities in the assigned geography ?? Supports surgical implanting sites ?? Drives clinical excellence ?? Partners with Territory Manager Apply Here: https://lnkd.in/gZRPwkiZ Review Safety Information: vivistim.com/safety #vivistim #pt #ot #neuro #medicaldevice #therapydevelopmentspecialist #strokecare #hcp #healthcare #recruiting #hr #careeropportunities #hybrid #remote #innovation

    • MicroTransponder, one of the fastest-growing stroke companies, is hiring OTs and PTs for its Therapy Development Specialist role in key markets.
  • ?? Austin -- Come join one of the fastest-growing stroke companies! ?? Here's how being "All-In" with MicroTransponder renews hope for chronic ischemic stroke survivors and their caregivers. ?? ?? Vivistim is the first and only FDA-approved intervention clinically proven to help chronic ischemic stroke survivors regain 2-3 times more upper extremity function than high-intensity stroke therapy alone. ?? Vivistim is an implanted device that a therapist pairs with vagus nerve stimulation (VNS) during high-repetition, goal-oriented therapy tasks. ?? Vivistim helps increase neuroplasticity so stroke survivors can make unprecedented gains with their hands and arms during activities of daily living. ?? Real-world data presented at the 2025 International Stroke Conference by two independent comprehensive stroke centers complements the published clinical studies proving the effectiveness of Paired VNS Therapy for chronic stroke survivors. ?? Vivistim programs have been integrated into 20% of Joint Commission Comprehensive Stroke Centers and 50% of Becker's 2024 100 Great Neuro and Spine Programs Apply Here: https://lnkd.in/gZRPwkiZ Review Safety Information: vivistim.com/safety #nowhiring #vivistim #neuro #medicaldevice #medicaldevicesales #territorymanager #strokecare #hcp #healthcare #recruiting #hr #careeropportunities #hybrid #remote #innovation

    • MicroTransponder, one of the fastest growing stroke companies, is now hiring territory managers.
  • ?? Philadelphia -- OTs / PTs - Bring your passion for neuro-focused therapy to one of the fastest-growing stroke companies! MicroTransponder is #nowhiring Therapy Development Specialists in key markets. ?? ?? Prior experience as occupational or physical therapist ?? Identify stroke survivors for Vivistim Therapy ?? “Vivistim Paired VNS Patient Expert” ?? Passionate patient advocate ?? Manages and expands stroke rehabilitation facilities in the assigned geography ?? Supports surgical implanting sites ?? Drives clinical excellence ?? Partners with Territory Manager Apply Here: https://lnkd.in/gZRPwkiZ Review Safety Information: vivistim.com/safety #vivistim #pt #ot #neuro #medicaldevice #therapydevelopmentspecialist #strokecare #hcp #healthcare #recruiting #hr #careeropportunities #hybrid #remote #innovation

    • MicroTransponder, one of the fastest-growing stroke companies, is hiring OTs and PTs for its Therapy Development Specialist role in key markets.
  • ?? Milwaukee -- Come join one of the fastest-growing stroke companies! ?? Here's how being "All-In" with MicroTransponder renews hope for chronic ischemic stroke survivors and their caregivers. ?? ?? Vivistim is the first and only FDA-approved intervention clinically proven to help chronic ischemic stroke survivors regain 2-3 times more upper extremity function than high-intensity stroke therapy alone. ?? Vivistim is an implanted device that a therapist pairs with vagus nerve stimulation (VNS) during high-repetition, goal-oriented therapy tasks. ?? Vivistim helps increase neuroplasticity so stroke survivors can make unprecedented gains with their hands and arms during activities of daily living. ?? Real-world data presented at the 2025 International Stroke Conference by two independent comprehensive stroke centers complements the published clinical studies proving the effectiveness of Paired VNS Therapy for chronic stroke survivors. ?? Vivistim programs have been integrated into 20% of Joint Commission Comprehensive Stroke Centers and 50% of Becker's 2024 100 Great Neuro and Spine Programs Apply Here: https://lnkd.in/gZRPwkiZ Review Safety Information: vivistim.com/safety #nowhiring #vivistim #neuro #medicaldevice #medicaldevicesales #territorymanager #strokecare #hcp #healthcare #recruiting #hr #careeropportunities #hybrid #remote #innovation

    • 该图片无替代文字
  • ?? Chicago -- OTs / PTs - Bring your passion for neuro-focused therapy to one of the fastest-growing stroke companies! MicroTransponder is #nowhiring Therapy Development Specialists in key markets. ?? ?? Prior experience as occupational or physical therapist ?? Identify stroke survivors for Vivistim Therapy ?? “Vivistim Paired VNS Patient Expert” ?? Passionate patient advocate ?? Manages and expands stroke rehabilitation facilities in the assigned geography ?? Supports surgical implanting sites ?? Drives clinical excellence ?? Partners with Territory Manager Apply Here: https://lnkd.in/gZRPwkiZ Review Safety Information: vivistim.com/safety #vivistim #pt #ot #neuro #medicaldevice #therapydevelopmentspecialist #strokecare #hcp #healthcare #recruiting #hr #careeropportunities #hybrid #remote #innovation

    • MicroTransponder, one of the fastest-growing stroke companies, is hiring OTs and PTs for its Therapy Development Specialist role in key markets.
  • ?? Los Angeles -- Come join one of the fastest-growing stroke companies! ?? Here's how being "All-In" with MicroTransponder renews hope for chronic ischemic stroke survivors and their caregivers. ?? ?? Vivistim is the first and only FDA-approved intervention clinically proven to help chronic ischemic stroke survivors regain 2-3 times more upper extremity function than high-intensity stroke therapy alone. ?? Vivistim is an implanted device that a therapist pairs with vagus nerve stimulation (VNS) during high-repetition, goal-oriented therapy tasks. ?? Vivistim helps increase neuroplasticity so stroke survivors can make unprecedented gains with their hands and arms during activities of daily living. ?? Real-world data presented at the 2025 International Stroke Conference by two independent comprehensive stroke centers complements the published clinical studies proving the effectiveness of Paired VNS Therapy for chronic stroke survivors. ?? Vivistim programs have been integrated into 20% of Joint Commission Comprehensive Stroke Centers and 50% of Becker's 2024 100 Great Neuro and Spine Programs Apply Here: https://lnkd.in/gZRPwkiZ Review Safety Information: vivistim.com/safety #nowhiring #vivistim #neuro #medicaldevice #medicaldevicesales #territorymanager #strokecare #hcp #healthcare #recruiting #hr #careeropportunities #hybrid #remote #innovation

    • MicroTransponder, one of the fastest growing stroke companies, is now hiring territory managers.
  • ?? NEWS ALERT ?? With this funding we're transforming the stroke continuum of care by establishing Vivistim Therapy? as the standard of care for chronic stroke recovery. ?? "The MicroTransponder executive leadership team is building the company in a very thoughtful way to establish Vivistim Therapy? as the standard of care for stroke survivors. We're excited by the combination of commercial excellence and the overwhelmingly positive clinical outcomes that show material improvements in stroke survivors' quality of life with Paired VNS? Therapy." ~Casey Tansey, a USVP general partner and MicroTransponder board member. Tap here to view the press release in our news room and review safety information: https://qrcodes.pro/vbdPY7

    • MicroTransponder Secures $65 Million to Enhance Vivistim Adoption for Chronic Stroke Recovery

关联主页

相似主页

查看职位

融资